Which pricing strategy was first pioneered for high-cost gene therapies to address concerns about one-time treatments with long-term benefits?

In the complex world of medical product pricing, pharmaceutical companies must balance research investment, market access, and patient affordability. This poll explores how innovative pricing models are being used for breakthrough treatments. Understanding these strategies provides insight into the evolution of healthcare economics and the future of patient access to cutting-edge therapies.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Outcome-based installment plans (paying only if treatment continues to work)
Subscription models (monthly fee for unlimited access)
Tiered pricing based on patient income level
Bundle pricing with companion diagnostics